Fingerprint
Dive into the research topics where SunYoung Rha is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Conversion Therapy for Stage IV Gastric Cancer: Report From the Expert Consensus Meeting at KINGCA WEEK 2024
Kim, T. H., Uyama, I., Rha, S. Y., Bencivenga, M., An, J., Wyrwicz, L., Koo, D. H., van Hillegersberg, R., Lee, K. W., Li, G., Yoshikawa, T., Badgwell, B., Lorenzen, S., Kim, I. H., Lee, I. S., Han, H. S. & Hoon, H., 2025 Jan, In: Journal of Gastric Cancer. 25, 1, p. 133-152 20 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Link opens in a new tab Citations (Scopus) -
Efficacy of the first-line immune checkpoint inhibitor plus chemotherapy for gastroesophageal cancer: A meta-analysis of phase III trials including unreported PD-L1 subgroups
Lee, C. K., Park, S., Lee, Y., Yun, C., Hong, M., Nam, C. M., Chung, H. C. & Rha, S. Y., 2025 Jul 28, In: Cancer Letters. 623, 217718.Research output: Contribution to journal › Article › peer-review
2 Link opens in a new tab Citations (Scopus) -
Identifying Trends in Oncology Research through a Bibliographic Analysis of Cancer Research and Treatment
On behalf of the 50th Anniversary Committee of the Korean Cancer Association, 2025 Jan, In: Cancer Research and Treatment. 57, 1, p. 11-18 8 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Citation (Scopus) -
INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer
Pavlakis, N., Shitara, K., Sjoquist, K., Martin, A., Jaworski, A., Tebbutt, N., Bang, Y. J., Alcindor, T., O'Callaghan, C., Strickland, A., Rha, S. Y., Lee, K. W., Kim, J. S., Bai, L. Y., Hara, H., Oh, D. Y., Yip, S., Zalcberg, J., Price, T. & Simes, J. & 1 others, , 2025 Feb 1, In: Journal of Clinical Oncology. 43, 4, p. 453-463 11 p.Research output: Contribution to journal › Article › peer-review
16 Link opens in a new tab Citations (Scopus) -
Predictive Value of the nProfiler 1 Assay for the Efficacy of Adjuvant S-1–Based Doublet Chemotherapy in Stage III Gastric Cancer: A Post-Hoc Analysis of a Randomized Phase III Trial
Lee, D. K., Lee, C. K., Kim, H. S., Sym, S. J., Zang, D. Y., Kim, K. H., Lim, J. H., Kim, H. S., Lee, K. H., Gee, H. Y., Rha, S. Y., Kim, H. & Jung, M., 2025 Jul, In: Cancer Research and Treatment. 57, 3, p. 770-780 11 p.Research output: Contribution to journal › Article › peer-review
Open Access